AI assistant
EyePoint Pharmaceuticals, Inc. — Director's Dealing 2014
May 7, 2014
32254_dirs_2014-05-07_b80110fe-b912-4056-914b-ff88de9aec76.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: pSivida Corp. (PSDV)
CIK: 0001314102
Period of Report: 2014-05-05
Reporting Person: Ashton Paul (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-05 | Common Stock | M | 3500 | $1.13 | Acquired | 444241 | Direct |
| 2014-05-05 | Common Stock | S | 3500 | $4.01 | Disposed | 440741 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-05 | Stock Option (Right to Buy) | $1.13 | M | 3500 | Disposed | 2018-11-18 | Common Stock (3500) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 16781 | Indirect |
Footnotes
F1: Shares sold pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person with respect to the Common Stock of the Issuer.
F2: The option was granted on 11/18/2008 and vested in four equal annual installments beginning on the first anniversary of the date of grant.
F3: Shares held by the Paul Ashton Children's Irrevocable Trust, of which the Reporting Person's minor children are the beneficiaries. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.